Who are Magnesium Sulfate, Heptahydrate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Perioperative magnesium sulfate, Magnesium Sulfate low dose.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/magnesium-sulfate-heptahydrate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Magnesium Sulfate, Heptahydrate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Magnesium Sulfate, Heptahydrate (Magnesium Sulfate, Heptahydrate) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte supplement / anticonvulsant / bronchodilator. Area: Obstetrics, Neurology, Cardiology, Pulmonology.

marketed Electrolyte supplement / anticonvulsant / bronchodilator NMDA receptor, voltage-gated calcium channels Obstetrics, Neurology, Cardiology, Pulmonology Small molecule Live · refreshed every 30 min

Target snapshot

Magnesium Sulfate, Heptahydrate (Magnesium Sulfate, Heptahydrate) — University of Utah. Magnesium sulfate acts as a physiological calcium antagonist and NMDA receptor antagonist, reducing neuronal excitability and smooth muscle contractility.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Magnesium Sulfate, Heptahydrate TARGET	Magnesium Sulfate, Heptahydrate	University of Utah	marketed	Electrolyte supplement / anticonvulsant / bronchodilator	NMDA receptor, voltage-gated calcium channels
Perioperative magnesium sulfate	Perioperative magnesium sulfate	Instituto Mexicano del Seguro Social	marketed	Electrolyte supplement / NMDA receptor antagonist	NMDA receptor, voltage-gated calcium channels
Magnesium Sulfate low dose	Magnesium Sulfate low dose	University of Monastir	phase 3	Electrolyte supplement / anticonvulsant	NMDA receptor, voltage-gated calcium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte supplement / anticonvulsant / bronchodilator class)

University of Utah · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Magnesium Sulfate, Heptahydrate — Competitive Intelligence Brief. https://druglandscape.com/ci/magnesium-sulfate-heptahydrate. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab